Background: The novel coronavirus disease 2019 (COVID-19) has become a global public health emergency. Computed tomography (CT) offers valuable clues to the diagnosis of COVID-19. However, little is known about the correlation between dynamic changes of CT scores and therapeutic response in the course of COVID-19. Objectives: To describe the temporal changes of CT findings and characterize the time window of disease progression on the follow-up CT scans of patients with COVID-19. Patients and Methods: In this historical cohort study performed in Shanghai, China, the follow-up chest CT images of 91 patients with COVID-19 with different therapeutic responses were reviewed in multiple centers, with an emphasis on characterizing the changing trend of CT scores for lung lesions at 13-15 days after the symptom onset and thereafter. The CT score curve patterns were categorized into type 1 (characterized by an increase to the peak level, followed by a decrease), type 2 (characterized by a steady change without an obvious peak), and type 3 (characterized by a progressive increase). Results: The CT scores of the progression group (n = 9) with a longer time to the peak were significantly higher than those of the non-progression group (n = 82) on the first day and days 13-15 (P < 0.05), except for the median CT scores before days 13-15. The CT curve type 1 and type 2 were commonly observed in the non-progression group (63.4% and 36.6%, respectively), while type 3 was more common in the progression group (88.9%). Conclusion: Most patients with COVID-19 show favorable responses to clinical treatments in Shanghai. Thirteen to fifteen days after the symptom onset can be considered as a turning point for the therapeutic response. The CT curve type 3 usually represents a poor response. The CT scores of patients with different therapeutic responses may overlap before days 13-15. The changing trend of longitudinal CT scores may contribute to the prediction of disease progression.
Correlation between dynamic changes of chest ct findings and therapeutic response of covid-19: A multicenter experience in shanghai, china